Abstract
Introduction

Hemophagocytic syndrome (HPS) is characterized by high fever, cytopenia, hepatosplenomegaly, liver dysfunction, coagulopathy, and pathologic findings of systemic hemophagocytosis, including the bone marrow. Various viruses trigger this syndrome. Proliferation of virus-infected T cells is a primary feature of the disease. Impaired function of natural killer (NK) cells and cytotoxic T cells (CTL) together with unrestricted release of inflammatory cytokines, such as interferon-γ and tumor necrosis factor-α, are prominent pathophysiological characteristics of HPS (1-5). In particular, Epstein-Barr virus (EBV) is the major triggering factor
of virus-associated hemophagocytic syndrome (VAHS) (1) (2) (3) (4) (5) , the outcome of which is dismal unless optimal treatment is rapidly instituted (1) (2) (3) (4) (5) (6) . We previously reported an apparently immunocompetent patient who developed two episodes of non-EBV-associated HPS separated by a two-year healthy interval (7) . This patient enjoyed a normal healthy life for the six years subsequent to the last episode and then developed self-limited infectious mononucleosis (IM), when infected with EBV.
Case Report
A 24-year-old man had a history of two separate episodes of non-EBV-associated HPS at the ages of 16 and 18 with a totally healthy interval. He had been well and active in public service except for occasional mild flu-like symptoms during the six-year period after the second episode of HPS, which was reported in our previous publication (7) . In both episodes of HPS, steroid pulse therapy was effective and led to complete recovery (7) 51 Cr-releasing assay showed about 60% killing of K562 cells at an effector/target ratio of 20, as described previously (7, 8) .
He was admitted to the Ohtsu Red Cross Hospital in early August 2002, complaining of fever and general malaise that (3) (4) (5) (6) 15 (16, 17) . However, the present patient showed normal NK activity, and the expression of cytoplasmic perforin in NK/CTL cells was confirmed to be within the normal range (Fig. 2) 
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Discussion
Supportive care and specific treatment for the underlying infection is generally associated with a high chance of recovery and a good outcome for patients with reactive HPS induced by pathogens other than EBV (3-5, 9). Although the exact incidence of the development of HPS during initial EBV infection is not known, EBV often causes severe VAHS, (summary: http://www.cdc.gov/ncidodeid/vol6no6/ fisman_refs.htm) (3). Such EBV-associated HPS requires chemotherapy and, if necessary, stem cell transplantation (1-6, 9). In EBV-associated HPS, virus-infected T/NK cells have been demonstrated to be clonally expanded in a similar manner to those in EBV-positive T/NK-cell lymphoma (10-12). Recent findings of the EBV tropism in lymphocyte subpopulations revealed differential virus-cell inter-actions within the EBV-related diseases. EBV infection is predominantly found in CD8 + T cells during EBV-associated HPS and in CD4 + T cells or NK cells during chronic active EBV infection (CAEBV), while the majority of EBV infected cells are found in B cells during acute IM (13). CD8 + T cells, as the main target of EBV in EBV-associated HPS, have two potent cytotoxic systems, the Fas/Fas ligand and the perforin-granzyme system. A marked elevation in the soluble form of Fas ligand was noted in EBV-associated HPS (13). The loss of function of perforin by gene mutations was reported in familial hemophagocytic lymphohistiocytosis (FLH), which is usually a disease of infants and shows similar clinical manifestations to EBV-associated HPS (14). Impaired function of NK cells and CTL is characteristic of both genetic and acquired form of HPS (1-6). However, most adolescent/adult patients with HPS have no known genetically confirmed underlying immune defects. It is less clear how the functions of NK cells and CTL are impaired in such apparently immunocompetent patients who develop HPS. Pathogens may interfere with the function of NK cells and CTL through specific proteins and/or high serum levels of cytokines to evoke the uncontrolled proliferation of CTL and multiple organ failure via excessively activated macrophages (3-5). In EBV-associated HPS, analyses of cytokine patterns suggest that the TH1 immune response is poorly or inappropriately regulated
